Point72 Asset Management, L.P. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34
-100.0%
9
-100.0%
0.00%
Q1 2023$122,884
-98.9%
36,682
-89.0%
0.00%
-100.0%
Q3 2021$11,647,000332,2000.05%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$22,222,0001.76%
EcoR1 Capital, LLC 5,376,134$48,063,0001.53%
Cormorant Asset Management, LP 1,679,442$15,014,0000.89%
CM Management, LLC 100,000$894,0000.68%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 596,800$5,335,0000.40%
PDT Partners, LLC 278,487$2,490,0000.19%
Ikarian Capital, LLC 116,600$1,043,0000.16%
HighVista Strategies LLC 20,659$185,0000.15%
Aristides Capital LLC 35,132$314,0000.14%
Parkwood LLC 71,932$643,0000.11%
View complete list of ATEA PHARMACEUTICALS INC shareholders